Have you taken a Color COVID-19 test and are looking for results? Click here
Unlock health insights through population genomics.
We power the future of healthcare.
Have you taken a Color COVID-19 test and are looking for results? Click here
Color is launching a high throughput, CLIA-certified COVID-19 testing laboratory integrated with public health tools. The testing facility, based in Burlingame, CA, will begin processing clinical samples to support public health efforts with a near-term goal of performing 10,000 tests per day. To learn more about this initiative, email us at covid-response@color.com.
Learn More
NIH awards $4.6 million to Color to provide genetic counseling and technological infrastructure for the million-person All of Us Research Program.
Read the press release
A note to healthcare providers seeking hereditary genetic testing:
Color’s hereditary genetic testing operations continue. Continue serving your patients through saliva kits that can be shipped to their homes. Click here >
Activate patients and their families with precision health data, including clinical-grade genetics, combined with best-in-class engagement software and tools.
Use individual-level risk assessment models to identify the right clinical resources—and deliver personalized, quality care to each patient.
Remove traditional constraints on capacity with virtual and convenient workflows like health history data collection and appointment scheduling.
From the National Institutes of Health’s All of Us research program, to premier health systems, and partnerships with leading employers around the world.
Bring innovation to patient care delivery.
Attract new patients in a competitive market with easy access to clinical-grade genetic information.
Manage patient health at the individual and population levels with ongoing data collection.
Drive desired behavior with digital onboarding and routing to the right care pathways for each patient.
Transform your cost structures with digital tools to make virtual and in-person clinical services more efficient.
Learn MoreReturn genetic results to your population at scale.
WISDOM is providing genetic testing for 100,000 women to make breast cancer screening more effective.
MAGENTA provides genetic testing and tele-counseling to women at high risk of cancer.
GENtleMEN provides genetic testing and counseling to men with metastatic prostate cancer.
Transform your employees’ engagement in their health decisions.
Activate employees with clinical-grade genetics, personal and family health history, and other insights.
Get employees to be more proactive about their health with personalized routing to relevant screening guidelines and benefits programs.
Mitigate costly health events by helping high-risk populations earlier.
Receive custom reports with ongoing aggregated insights into your population’s health.
Learn More
The partnership will combine Color’s capabilities in medical-grade genetics, clinical services and patient engagement and the health system’s experience with personalized medicine and integrating it into routine patient care.
The partnership could enable Verily to incorporate data on genetic risk factors into its various clinical studies, leading to a more in-depth and holistic understanding of health.
Color won the award over other bidders for several reasons. “They’ve shown a track record that they’ve been able to deliver this type of service to people,” Devaney says, and “they have really strong software capabilities.”
Simply fill out this form and we’ll have a member of our team reach out
to you right away! Interested in offering Color to your patients? Click here. Interested in a Color test for yourself? Click here